H.I.G. HealthBridge Partners β Full Portfolio
27 tracked investments Β· listed companies and verified rows first
Exagen develops diagnostic and monitoring tests for autoimmune diseases, including tools to distinguish connective tissue disease and assess lupus prognosis and progression.
BiotechDigital HealthHealthtechMedical DevicesVista, US
Thierry Dervieux(Executive Officer)Wendy Swedick(Executive Officer)Arthur Weinstein(Director)James L.L. Tullis(Director)Fortunato R. Rocca(Executive Officer, Director)John M. Radak(Director)
BiotechSan Diego, US
Kathleen D. Scott(Chief Financial Officer, Secretary and Treasurer)Judy Caron(Chief Operating Officer)David F. Hale(Chairman of the Board of Directors, Acting President and CEO)Brian Dorsey(Director)Daniel Becker(Director)Joshua Richardson(Director)
Board seatAlex ZissonΒ· per SEC Form D Β· $3.8M raise Β· filed May 2018
BiotechBothell, US
Randall Schatzman(Executive Officer, Director)James Bucher(Executive Officer)Clay Siegall(Director)Jeffrey Smith(Executive Officer)Paul Carter(Director)Randal Hassler(Executive Officer)
Contract development and manufacturing organization (CDMO) providing full-service cGMP outsourcing for intermediates and APIs.
Global clinical research organization providing early-stage clinical trial and bioanalytical services, headquartered in Lincoln, NE.
Click Therapeutics develops software-based prescription medical treatments for patients with unmet medical needs, combining neuroscience with digital technology to create a new treatment modality.
Digital HealthHealthtechMedical DevicesNew York, US
David B. Klein(Founder and CEO)Randall Stanicky(Executive Officer)Nicholas Schork(Director)Victor Gao(Director)Emile Westergaard(Director)
BoardAlex Zisson(Director)
HealthtechMenlo Park, US
Robert C. Bellas, Jr.(Director)K. Angela Macfarlane(Executive Officer, Director)Jim Glasheen(Director)Andy Corley(Director)Aaron Davidson(Director)William J. Link, Ph.D.(Director)
Develops innovative medical devices for ophthalmology, general, and specialty surgery markets.
Develops and commercializes energy-based soft tissue ablation devices for various clinical markets.
Develops and commercializes medical devices based on a proprietary imaging platform for diagnosis and treatment of diseases.
On Target Labs develops intraoperative molecular imaging agents that enable surgeons to visualize and detect cancerous tissue during procedures.
BiotechHealthtechMedical Devices
Brings innovative products to underserved patients affected by rare diseases.
Specialty pharmaceutical company built on patent-protected dermal delivery technologies.
Develops and markets generic and specialty branded pharmaceutical products, based in New Brunswick, NJ.
Develops oncology drugs for hematologic cancers; acquired by Cephalon Inc. in 2005.
Leading supplier of murine research models for pharmaceutical, biotechnology, CRO, and academic research clients.
HealthtechSan Clemente, US
Kathy Tune(Director)Peter Justin Klein(Director)Sigrid Van Bladel(Director)Jeff Swiecki(Executive Officer)Earl R. Fender(Executive Officer, Director)Guy P. Nohra(Director)
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.
